Division 10.3 Consideration may be given to the issuing/renewal of group 2 licences to drivers with diabetes mellitus. When treated with medication which carries a risk of inducing hypoglycaemia (that is, with insulin, and some tablets), the following criteria should apply:F1
United Kingdom
-
no severe hypoglycaemic events have occurred in the previous 12 months,
-
the driver has full hypoglycaemic awareness,
-
the driver must show adequate control of the condition by regular blood glucose monitoring, at least twice daily and at times relevant to driving,
-
the driver must demonstrate an understanding of the risks of hypoglycaemia,
-
there are no other debarring complications of diabetes.
Moreover, in these cases, such licences should be issued subject to the opinion of a competent medical authority and to regular medical review, undertaken at intervals of not more than three years.